DBIBB - Moligand™, 10 mM in DMSO , CAS No.1569309-92-7

CAS: 1569309-92-7 Cat. No.: D1495097 Formula: C23H20N2O6S Peso molecolare: 452.48 PubChem CID: 73296092
Disponibile su ordine
QUALITÀ & PUREZZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
1ml
D1495097-1ml
Su ordinazione · 8–12 settimane
176,93€
Enter a quantity for the sizes you want to add.

Panoramica

DBIBB is a specific nonlipid agonist of the type 2 G protein coupled receptor for lysophosphatidic acid (LPA2). DBIBB mitigates the gastrointestinal radiation syndrome, increases intestinal crypt survival and enterocyte proliferation, and reduces apoptosis . DBIBB represents a agent candidate capable of mitigating acute radiation syndrome caused by high-dose γ-radiation to the hematopoietic and gastrointestinal system.

Specifiche

Specifiche e purezza
Moligand™, 10 mM in DMSO
Condizioni di conservazione di stoccaggio
Store at -80°C
Spedito in
Dry ice packs + Cold packs
Questo prodotto richiede spedizione a catena fredda. I servizi di terra e altri servizi economici non sono disponibili.
Grado
Moligand™
Nomi e identificatori
Isomeri SMILES
C1=CC=C(C(=C1)C(=O)O)S(=O)(=O)NCCCCN2C(=O)C3=CC=CC4=C3C(=CC=C4)C2=O
PubChem CID
73296092
Peso molecolare
452.48

Dati avanzati

Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No tested applications or protocols are provided in the Product Data for this item.

  • Validated applications (e.g., WB, IHC, IF, FC, enzymatic assays): Not specified for this item; refer to CoA/Spec Sheet.
  • Recommended concentrations/dilutions: Not specified for this item; refer to CoA/Spec Sheet.
  • Positive controls: Not specified for this item; refer to CoA/Spec Sheet.

If employing this compound in screening assays, develop assay-specific protocols, validate solvent tolerances, and confirm stability—however, such guidance is general and not item-specific.

Biological Roles

Item-specific biological roles or targets are not provided for this SKU.

  • Known target(s), pathway involvement, and mechanism of action: Not specified for this item; refer to CoA/Spec Sheet or screening annotations if available.

General context for small-molecule library members (literature/general):

  • Library compounds may be designed to sample chemical space associated with common protein families (e.g., kinases, GPCRs, ion channels, epigenetic enzymes). Without item-specific data, no claim can be made about the relevance of DBIBB to any of these classes.
  • In chemical biology, such compounds are used as putative ligands or probes to modulate protein function in vitro or in cells to generate hypotheses; downstream validation requires orthogonal assays and target deconvolution.
  • Annotated roles (if any) typically include activity values (e.g., IC50, KD) under defined conditions; these are essential for interpretation and reproducibility and must be sought from primary data sources and the item’s documentation.

Important note:

  • This product is for research use only. No medical or clinical claims are made or implied. If used in biological experiments, ensure appropriate controls (vehicle, inactive analogs) and report final solvent percentages, exposure times, and concentrations used.
Buffer Applications

This item is a small-molecule library compound; it is not a buffering reagent. No buffer system parameters or recipes apply specifically to this compound.

  • Buffer capacity/pKa ranges: Not applicable; not specified for this item.
  • Recommended buffer systems: Not applicable.

Practical note (general):

  • When using small molecules in biological assays, choose assay buffers (e.g., PBS, HEPES, Tris) based on the biology, not the compound. Ensure compound compatibility with buffer components and verify solubility at working concentrations (consider co-solvent limits such as ≤1% DMSO for cell-based assays).
Green Alternatives

Because the compound’s identity and solvent/processing requirements are not specified, green chemistry guidance must remain general.

General greener-practice strategies (literature/general):

  • Solvent selection: Favor greener solvents where compatible—e.g., ethanol, isopropanol, 2-MeTHF, CPME, propylene carbonate—over chlorinated or high-toxicity aprotic solvents. Verify solubility and assay tolerance.
  • Energy efficiency: Conduct reactions/assays at ambient temperature when feasible; leverage microwaves or flow chemistry to reduce time/energy if synthesis is involved.
  • Scale and waste: Miniaturize screening assays (384/1536-well) to reduce solvent use and waste. Use sealed plates to limit evaporation and emissions.
  • Purification: Prefer crystallization or minimal-sorbent flash over extensive HPLC where suitable; choose greener eluents (e.g., EtOAc/hexanes over DCM) when compatible with the compound.
  • Life-cycle considerations: Consolidate shipments and maintain ultra-cold chain only as needed to reduce dry ice usage and repacking frequency.

Illustrative comparison (general):

  • Conventional: DCM, DMF, NMP (effective but higher hazard/impact).
  • Greener options: EtOAc, 2-MeTHF, MeTHF/water biphasic systems, acetone, IPA (often lower toxicity/impact).

Item-specific choices (solvent, stabilizer, quench) cannot be recommended without the structure and property data. Consult the CoA/Spec Sheet for any constraints that might preclude specific green alternatives (e.g., hydrolysis sensitivity, photolability).

Pharmaceutical Uses

No excipient or pharmacopeial information is provided for this item, and no formulation role is specified.

  • Pharmacopeia status (USP/EP/JP): Not specified for this item; refer to CoA/Spec Sheet.
  • Typical pharmaceutical roles: Not specified for this item.

General context (literature/general):

  • Small-molecule library compounds are usually employed in discovery and preclinical research settings rather than as formulated excipients or drug substances. Any progression toward development would require comprehensive CMC characterization (identity, purity profile, polymorph, stability, impurity fate/tox), none of which is provided here.

Compliance note:

  • For research use only. Not for human or veterinary use, not for diagnostic procedures, and not for clinical or manufacturing applications without further qualification and regulatory assessment.
Physical Properties

Item-specific values are not provided in the Product Data. Do not infer values; consult the CoA/Spec Sheet for definitive specifications.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting/Freezing Point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling Point: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive Index: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa/logP/logD: Not specified for this item; refer to CoA/Spec Sheet.

General considerations (literature/general):

  • Small-molecule library compounds are frequently supplied as solids (amorphous or crystalline) with variable solubility; DMSO is commonly used for primary stock solutions due to broad solvating power.
  • Hygroscopicity and polymorphism can influence weighed mass accuracy and dissolution; minimize ambient exposure and record environmental conditions when preparing stocks.
  • If the compound is moisture- or air-sensitive (unknown for this item), prepare and store solutions under inert atmosphere, using anhydrous solvents and septum-capped vials.
  • When physical form is unknown, begin with a micro-scale solubility screen (e.g., DMSO, DMF, MeOH, ACN, PBS) at room temperature and 37 °C to establish workable stock conditions for assays (general practice).

Always rely on the CoA/Spec Sheet for certified item-specific values.

Quality and Grades
  • Grade/Purity (item-specific): Moligand™ (as provided). No numerical purity or stabilizer information is provided for this SKU. For quantitative specifications, refer to the CoA/Spec Sheet.

What Moligand™ typically implies (general/brand context):

  • Moligand™ denotes inclusion in a curated small-molecule/ligand library optimized for discovery workflows (e.g., screening, probe development, SAR expansion). Such collections often emphasize chemical diversity, compliance with common drug-likeness guidelines, and robust identity/quality documentation. This is general information on the grade family, not item-specific specifications.

Documentation and verification (best practice):

  • For each lot, verify identity using supplied structural identifiers (SMILES, InChIKey) and analytical data (e.g., NMR, LC–MS, HRMS) when available. Request the CoA for exact acceptance criteria (e.g., LC–MS purity basis, residual solvent limits) as these are Not specified for this item; refer to CoA/Spec Sheet.

Implications for use:

  • Library-grade materials are typically suitable for biochemical/cellular screening and early medicinal chemistry exploration when accompanied by fit-for-purpose purity and identity confirmation. If using in sensitive biophysical assays (SPR, ITC) or analytical methods (HPLC-UV), assess background absorbance and potential impurities.

Stabilizers/inhibitors:

  • Not specified for this item; refer to CoA/Spec Sheet. If stabilizers are present, consider their impact on bioassays and chromatography and plan appropriate controls or pre-purification if required.
Reaction and Applications

Item-specific reactivity and application scope are not provided. Without a defined structure or functional group set, synthetic reaction guidance for this specific compound cannot be given.

General applications of small-molecule library members (literature/general):

  • Chemical biology and screening: Employed as test ligands in enzyme or receptor assays, phenotypic screens, and binding studies (e.g., thermal shift, SPR, DSF), contingent on solubility and purity.
  • SAR development: Hits can be elaborated through scaffold modification once the core structure is known; typical follow-ups include substitution pattern changes, heterocycle swaps, or linker optimization.
  • Analytical profiling: LogP/logD, pKa, permeability (PAMPA, Caco-2), stability (chemical, photolytic), and solubility assessment to inform assay conditions and storage.

Practical tips (general):

  • Prepare concentrated DMSO stocks under dry conditions; aliquot to minimize freeze–thaw cycles. Validate solution stability (re-check by LC–MS after storage).
  • If undertaking derivatization chemistry, first secure full structural identity (NMR, HRMS) from the CoA and confirm reactive handles; then select reaction families accordingly (e.g., SNAr, amide coupling, cross-coupling), which cannot be specified here without the structure.

Note: For item-specific reaction recommendations, obtain the structural data and functional group annotations from the CoA/Spec Sheet.

Reaction Conditions

No item-specific reaction condition data (solvents, temperatures, catalysts, yields) are provided. Reaction guidance requires knowledge of the compound’s functional groups.

General guidance (literature/general):

  • If derivatization is intended, first confirm the presence of reactive handles (e.g., aryl halide for cross-coupling, carboxylic acid for amide formation, amine for acylation/alkylation) using the structure from the CoA/Spec Sheet.
  • Typical conditions by transformation class (examples only; not specific to this item):
    • Amide couplings: HATU/DIPEA or EDCI/HOBt in DMF/DCM, 0–25 °C.
    • Suzuki couplings: Pd(PPh3)4 or XPhos-type catalysts, base (K2CO3, Cs2CO3), dioxane/H2O or toluene/H2O, 25–100 °C.
    • Buchwald–Hartwig amination: Pd2(dba)3 or Pd precatalyst with dialkylbiaryl phosphines, toluene/dioxane, 60–110 °C.
    • Reductions: NaBH4 or catalytic hydrogenation (Pd/C) under H2 (1–5 atm) for reducible motifs.
  • Always perform small-scale scouting experiments and monitor by LC–MS/HPLC to establish feasibility and stability.

Important:

  • Do not apply these conditions to DBIBB without confirming compatibility. Obtain the item’s structure and any reactivity notes from the CoA/Spec Sheet.
Safety and Handling

Safety data specific to this item are not provided in the Product Data. Exercise prudent laboratory safety and consult the SDS prior to use.

Item-specific safety fields:

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification: Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (best practice):

  • Use in a chemical fume hood. Wear appropriate PPE: lab coat, safety glasses, and chemical-resistant gloves compatible with organic solvents.
  • Avoid inhalation, ingestion, and skin/eye contact. Prevent aerosol/mist formation when weighing or dissolving.
  • Storage incompatibilities are unknown for this item; segregate from oxidizers, acids/bases, and moisture until specific compatibility is known. Keep container tightly closed.
  • For potentially air/moisture-sensitive materials (unknown for this item), purge headspace with inert gas and use dry tools/solvents.

First-aid overview (general):

  • Skin/eye contact: Rinse with plenty of water for ≥15 min; remove contaminated clothing; seek medical attention as needed.
  • Inhalation: Move to fresh air; keep at rest; seek medical attention if symptoms persist.
  • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Waste and spills:

  • Contain and absorb small spills with inert material; dispose through licensed chemical waste programs in accordance with local regulations.

Always defer to the product’s SDS for authoritative, item-specific safety guidance.

Solvent Selection

Item-specific solubility is not provided; therefore, select solvents empirically, beginning with broadly compatible screening solvents.

Item-specific data: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for small-molecule library compounds (literature/general):

  • Primary stock solvent: DMSO is the default due to high solvency and compatibility with biochemical/cell assays. Start at 10–50 mM stock concentrations, adjusting to avoid precipitation.
  • Co-solvent strategies: For compounds with limited DMSO solubility, pre-dissolve in a small volume of DMF, MeOH, or ACN, then dilute with DMSO or aqueous buffers as needed. Maintain final assay DMSO ≤0.5–1% v/v where biologically relevant.
  • Aqueous buffers: Only if the compound exhibits sufficient ionization/hydrophilicity. Consider pH adjustments to improve solubility when acid/base functional groups are known (not known for this item).
  • Volatile organics: Use EtOH/MeOH sparingly in biological systems; verify tolerance of the assay or organism.

Comparison snapshot (general):

  • DMSO: maximal solvency; hygroscopic; higher viscosity.
  • DMF: strong solvency; more toxic; harder to remove.
  • ACN: good for LC compatibility; limited for highly lipophilic solids.
  • MeOH/EtOH: protic; can disrupt some protein assays.

Best practice:

  • Conduct a micro-scale solubility screen at room temp and 37 °C. Filter 0.2 µm if particulates persist. Document solvent lot, water content, and final percentages in assay-ready solutions.
Storage and Reconstitution

Item-specific conditions from Product Data:

  • Storage Conditions: Store at -80°C (item-specific; authoritative for this SKU).
  • Shipped In: Dry ice packs + Cold packs (item-specific).

Additional item-specific details:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Reconstitution solvent/concentration: Not specified for this item; refer to CoA/Spec Sheet.

General best practices for small-molecule library compounds (literature/general):

  • Upon receipt: Keep the container closed; equilibrate to room temperature in a desiccator before opening to minimize condensation. If supplied frozen, briefly thaw in a dry environment.
  • Aliquoting: Prepare single-use aliquots (e.g., DMSO stocks at 10–50 mM) in inert-atmosphere conditions if sensitivity is suspected. Store aliquots at -80°C to match the recommended storage.
  • Freeze–thaw: Minimize cycles; repeated freeze–thaw can accelerate degradation/precipitation, especially in DMSO. Use low-bind tubes and cap mats for plates.
  • Light/moisture sensitivity: Unknown for this item. As a precaution, protect from light and moisture; include desiccant and, if appropriate, inert headspace (N2/Ar).
  • Stability monitoring: Periodically verify integrity by LC–MS/HPLC and, if applicable, 1H NMR for solid material after extended storage.

Always defer to the product’s CoA/Spec Sheet for any specific reconstitution instructions, concentration limits, and confirmed shelf-life under the stated storage conditions.

Structure and Identity

Brief overview: This listing (DBIBB, CAS 1569309-92-7) is part of a small-molecule/compound library collection. Item-specific structural identifiers are not provided in the Product Data.

  • SKU: D1495097
  • Product Name: DBIBB
  • CAS: 1569309-92-7 (item-specific)
  • CID: 73296092 (item-specific)
  • Chemical Name: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Without a provided structure, specific functional groups, ring systems, and stereochemical descriptors cannot be confirmed for this item.
  • For library compounds, typical features may include one or more heterocycles, aryl/alkyl substituents, and functional handles (e.g., halides, amides, nitriles) suitable for SAR exploration (literature/general).

2D structure description (general):

  • Not available for this specific item. Request the structure drawing or SDF/Molfile from the CoA/Spec Sheet to evaluate atom connectivity, heteroatom placement, and potential H-bond donor/acceptor counts (general best practice).

Documentation note:

  • For precise cheminformatics work (registration, inventory, screening data capture), use the authoritative structure file and identifiers from the item’s CoA or specification sheet.
Synthetic Utility

Item-specific synthetic functionality cannot be described without a structure. Consequently, concrete retrosynthetic or forward-synthesis guidance for DBIBB is not possible from the provided data.

General notes (literature/general):

  • If the compound bears common functional groups (e.g., aryl halide, amine, carboxylate, nitrile, azide), it may be amenable to standard transformations such as cross-couplings (Suzuki, Buchwald–Hartwig), amide couplings, reductions/oxidations, and cyclizations.
  • Library members that include bioorthogonal handles (alkyne/azide) enable tagging via CuAAC/SPAAC. Others with electrophilic warheads (e.g., acrylamides) can serve as covalent probes; verify presence from structure and CoA.
  • For SAR development, identify modifiable positions and potential liabilities (e.g., metabolically soft spots, hydrolysis-prone linkers) once the structure is available. Parallel synthesis or DNA-encoded library follow-ups can expand around the core scaffold.

Actionable step:

  • Obtain the item’s structure (SMILES/SDF) and analytical package from the CoA/Spec Sheet to map functional groups and plan synthetic elaborations or analog generation.
Target Specificity

No target information is provided for this product.

  • Target/antigen: Not specified for this item; refer to CoA/Spec Sheet.
  • Binding site/epitope: Not applicable.
  • Species reactivity/clone/isotype: Not applicable.

Note: This product is a small-molecule library member, not an antibody or biological reagent with defined immunological specificity.

Hai bisogno di aiuto per scegliere la qualità?

La nostra guida alla selezione delle qualità copre purezza, stato dello stabilizzatore e idoneità all'applicazione per tutte le varianti del nostro catalogo.

Visualizza la guida alle qualità Moligand™ →

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.